Price redetermination for Omeprazole oral suspension (September and October 2023)
Following representations made by Community Pharmacy England, DHSC agreed to the following redeterminations for the September and October 2023 Drug Tariffs: the addition of licensed Omeprazole 1mg/1ml oral suspension sugar free (75ml) to Category C based on Rosemont Pharmaceuticals Ltd the deletion of unlicensed Omeprazole 5mg/5ml oral suspension from Part VIIIB Payment for September and [...]
The post Price redetermination for Omeprazole oral suspension (September and October 2023) appeared first on Community Pharmacy England.
Recent Comments